24 May 2018 10:43
24 May 2018
Instem plc
Â
("Instem" or the "Company")
Â
Result of AGM
Â
Instem (AIM: INS.L), a leading provider of IT solutions to the global early development healthcare market, announces that at its Annual General Meeting held today, all resolutions were duly passed.Â
Â
For further information, please contact:
Â
Instem plc | +44 (0) 1785 825 600 |
Phil Reason, CEO | |
Nigel Goldsmith, CFO | |
N+1 Singer (Nominated Adviser & Broker) | +44 (0) 20 7496 3000 |
Richard Lindley James White | |
Walbrook Financial PR | +44 (0) 20 7933 8000 |
Paul Cornelius | instem@walbrookpr.com |
Helen Cresswell Sam Allen  | |
Â
About Instem
Â
Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.
Â
Instem solutions are in use by customers worldwide and enable our clients to bring life enhancing products to market faster.
Â
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
Â
Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.
Â
To learn more about Instem solutions and its mission, please visit instem.com.
Follow the stocks